Needed Application Instructions

It is vital that applicants refer to the manual within the SF424 (R&R) Application Guide. except where prone to do otherwise (during this FOA or even in the Notice inside the NIH Guide for Grants and Contracts ). Conformance to everyone needs (inside the applying Guide along with the FOA) is needed and strictly enforced. Applicants must read and follow all application instructions within the Application Guide furthermore towards the program-specific instructions noted in Section IV. Once the program-specific instructions deviate from individuals within the Application Guide, continue with the program-specific instructions. Applications that don’t stay with these instructions might be delayed otherwise renowned for review.

Table of Contents

Part 2. Full Text of Announcement

Section I. Funding Chance Description

The Nation’s Institute on Substance Abuse (NIDA) announces the supply of NIH Dissertation Award grants (R36) to help substance abuse doctorate dissertation research in NIDA areas of priority (internet.drugabuse.gov/funding/funding-priorities ). Areas of focus include research on fundamental and clinical neuroscience and behavior, developmental trajectories, epidemiology, prevention, treatment, services, and/or in addition to sex/gender variations. Grant support should encourage doctorate candidates from numerous academic disciplines and programs to conduct research of these areas of interest to NIDA. It’s wanted this program may ultimately facilitate the entry of promising new investigators into the thought of substance abuse research and promote transdisciplinary collaborations.

Accordingly the NIH is continually encourage institutions to diversify their student and faculty populations and so to boost the participation of people presently underrepresented within the biomedical, behavior, clinical and social sciences for example: individuals from underrepresented racial and ethnic groups, people with disabilities, and people from socially, culturally, economically, or educationally disadvantaged backgrounds which have inhibited outstanding capacity to pursue be employed in health-related research.

Institutions must identify candidates who’ll increase diversity round the national or institutional basis. The NIH is especially thinking about encouraging the recruitment and retention within the following classes of candidates:

A. Individuals from racial and ethnic groups which have been proven using the National Science Foundation to obtain underrepresented in health-related sciences round the national basis (see data at internet.nsf.gov/statistics/showpub.cfm?TopID=2&SubID=27 as well as the newest number of Women, Minorities, and Persons with Disabilities in Science and Engineering ). The next racial and ethnic groups are really proven to get underrepresented in biomedical research: African Americans, Hispanic Americans, American Indians, Alaska Natives, Native Hawaiians, along with other Off-shore Islanders. In addition, it’s recognized that underrepresentation may vary from setting to setting individuals from racial or ethnic groups which can be convincingly shown to get underrepresented using the grantee institution must be requested to learn the program.

B. People with disabilities, who’re looked as individuals getting a real or mental impairment that substantially limits numerous major existence activities.

C. Individuals from disadvantaged backgrounds who’re looked as:

1. Those who derive from children through getting an annual earnings below established low-earnings thresholds. These thresholds originate from family size printed using the U.S. Bureau within the Census adjusted yearly for adjustments to the customer Cost Index and adjusted using the Secretary to be used in lots of health professions programs. The Secretary periodically publishes these earnings levels at HHS – Poverty Guidelines, Research, and Measurement. For people from low earnings backgrounds, the institution must manage to show such participants have qualified for Federal disadvantaged assistance or they’ve received the following school loans: Health Professions School Loans (HPSL), Loans for Disadvantaged Student Program, or they’ve received scholarships inside the U.S. Department of Medical health insurance Human Services underneath the Scholarship for individuals who’ve Exceptional Financial Need.

2. Those who derive from a social, cultural, or educational atmosphere for example that found in certain rural or inner-city environments which have demonstrably and lately directly inhibited the person from acquiring the understanding, skills, and skills essential to develop and take part in an analysis career.

Recruitment and retention of people from disadvantaged background (C1 and C2) would be best to highschool and possibly undergraduate candidates, but sometimes be harder to warrant for people beyond that much cla of cla of task.

Recent national data on doctorates earned by underrepresented minority U.S. citizens and permanent residents demonstrates a coninuing have to enhance diversity (internet.nsf.gov/statistics/sed/2011/start.cfm ).

NIDA supports greater than 80 5 % within the world’s research across the health regions of substance abuse and addiction. Research based on NIDA encompasses fundamental, behavior, and systems connected while using actual mechanisms and health connection between drugs of abuse. This FOA should be to provide students with grant-in-aid support to accomplish substance abuse dissertation research about the subject associated with the study into development, epidemiology, prevention, treatment, services, or in addition to sex/gender variations, and so enhance the pool of highly gifted substance abuse scientists who conduct research of these areas.

The descriptions listed below are types of the study foci in the grant program and they are provided to guide potential applicants to uncover whether confirmed scientific subject might be appropriate with this particular initiative. These descriptions aren’t must have been comprehensive. In addition, because of the complexity of substance abuse research, it’s allowed to conduct the suggested dissertation research along with a ongoing study to make use of extant data. Research focused on Aids/AIDS and Health Disparities are encouraged.

Studies of multiple factors that influence drug abuse outcomes. That’s, studies that examine genetic, nerve, biomedical, familial, behavior, ecological, social, cultural, developmental, psychopathological, and mental factors, their interactions, and mediating characteristics.

Studies within the underlying physiological and psychosocial mechanisms connected while using the transition from lower to bigger levels of drug participation and from bigger levels of drug participation to dependence and addiction.

Development and improvement of the way for studying substance abuse, including enhancements in measurement, advancement of improved sampling procedures, and refinement of analytic method of diverse populations across human development.

Advancement of innovative strategies to identify both physical (environmental) and social ecological/contextual characteristics of local neighborhoods that influence drug abuse, emerging drug abuse patterns, and adverse drug-related outcomes.

Delineation within the underlying dynamic causal mechanisms connected with drug abuse patterns and adverse drug-related outcomes by integrating individual, family, peer and community level factors. Mechanistic studies and research that address critical time points in development that may influece risk or resilience have interest.

Studies of emerging trends (e.g. club drugs, illicit prescription drugs abuse, tobacco along with other smoke products, etc.), including studies that report these trends to influences for example adjustments to social attitudes, new drugs of abuse, new patterns of self confidence and social networking, technology, new drug trafficking patterns, along with other macro-level changes.

Research on drug abuse and drug-related effects among racial/ethnic minority groups along with other underserved populations. Including studies that understand the reason for racial/ethnic disparities in drug abuse and social, behavior, and health outcomes associated with drug abuse across development.

Research to evaluate the finish consequence of mental health interventions when they’re youthful on subsequent substance abuse.

Studies to evaluate the level of smoothness, scope, and outcomes of drug-related trauma, violence and crime including violent and nonviolent crime, interpersonal violence, and drug abuse along with other comorbid mental and physical health issues.

Research to evaluate the finish consequence of drug abuse on adverse behavior, social, and health effects (e.g. trauma, violence, educational attainment, Aids) combined with role of unwanted effects on further drug participation.

Studies that apply insights from genetics, neurobiology, neurocognition, and physiology to tell prevention interventions and look for the final results of prevention interventions.

Studies across the effectiveness and/or effectiveness of substance abuse prevention programs and techniques which are broadly used but largely untested.

Studies to build up and look for the successOrusefulness of interventions adapted for several contexts, for instance healthcare settings and schools.

Methodological research to improve situation study of complex prevention trial data—for example, record modeling for multi-level data, analysis of longitudinal data, and research analyzing complex interactions between qualitative and quantitative outcome data.

Studies across the adoption, implementation, and sustainability of evidence-based substance abuse prevention interventions, including analysis of process data to uncover factors that consider quality of implementation and outcomes, or program sustainability.

Pilot substance abuse or drug-related Aids prevention studies made to identify novel strategies to risk reduction, for example through technology or new modalities.

Research fond of developing improved drug abuse prevention methods for high-risk populations for example subgroups with elevated rates of substance use, kids of substance users, and underage drinkers.

Behavior and integrative treatment research at NIDA is introduced getting a stage type of therapy development. For almost any detailed description in the model, furthermore to NIDA’s therapy development and testing priorities, browse the conduct Therapies Development Program Bulletins at: (https://grants.nih.gov/grants/guide/pa-files/PA-13-078.html https://grants.nih.gov/grants/guide/pa-files/PA-13-077.html https://grants.nih.gov/grants/guide/PA-files/PA-13-079.html ).

Types of behavior treatment research appropriate with this particular announcement include, but aren’t limited to another:

Utilizing genetic, neurobiological, neuropsychological, behavior, or any other diagnostic data to tailor treatment to specific subgroups.

Utilizing relevant research inside the animal model literature (e.g. avoidance and impulsivity paradigms) to build up or improve treatments/interventions.

Utilizing relevant research inside the developmental (e.g. fundamental research on familial and peer influences during adolescence) or social psychology (e.g. fundamental research on stereotyping) literatures to improve treatments.

Stage I studies developing or adapting behavior interventions that promote adherence to substance abuse pharmacotherapy.

Adapting/modifying evidence-based treating utilized in non-traditional and community settings, into community-friendly formats (e.g. individual to group, briefer formats, less intensive delivery, computer-aided delivery, etc.), and evaluating their resulting potency.

Developing sleep hygiene modules for incorporation into substance abuse treatment protocols for drug users with insomnia.

Developing and assessing treatment provider training procedures for evidence-based treatments (e.g. computerizing training procedures this may include initial training furthermore to supervision needs).

Developing interventions to promote adherence to treatment regimens in Aids+ drug users.

Computerizing, or partly computerizing evidence-based treating drug abuse disorders, and for Aids prevention interventions for people in substance abuse treatment

Developing interventions to lessen discomfort in individuals in love with prescription medications, non-drug mistreating populations, or people with chronic discomfort.

Research involving secondary analyses of existing behavior treatment research data sets to understand predictors, moderators, or mediators of treatment outcome, mechanisms of action of treatment, or unwanted effects of treatment on participants in many contexts (e.g. peer group, school, work, family) or on participants’ family people (e.g. children).

Performing secondary analysis of combined behavior and medicinal treatment numerous studies.

Research on instrument development and/or psychometric analysis of tools for the clinical assessment of substance abuse, treatment effectiveness, treatment fidelity, and Aids risk, or constructs considered as associated with mechanisms of action of behavior treatment effectiveness.

Research to build up and test a therapy module to get incorporated with a current therapy to deal with targeted issues (e.g. adding an Aids risk reduction module having a family therapy for drug-mistreating adolescents).

Research to integrate innovative health technologies into new or existing behavior and integrative treatments.

Research testing a principle of behavior change among drug-users in treatment (e.g. with the aid of more frequent or multi-method assessments with an existing study to be able to track behavior change after a while).

Advancement of improved medication compliance markers.

Advancement of medications to deal with Substance Related Disorders, including medications to stop smoking.

Studies within the neurodevelopmental variations among adolescents within the neurobiological processing of drug-related information, furthermore to variations generally reward valuation, and reinforcement (both bad and the good) in laboratory decision-making or imaging paradigms tightly related to treatment development.

Studies of developmental cognitive processes of rewards, losses, social cues in decision-making, and cost incentives which are tightly related to treatment and integration of relevant developmental cognitive processes into the introduction of treatments.

Studies to tell our knowledge of methods peer influence leads to selection processes in group treatment settings.

Studies involving neuroimaging along with other methods for characterize specific neurobiological circuitry during adolescence to tell treatment development (e.g. to uncover incentive-motivational circuitry which can be take part in emotional regulation, drug seeking, addiction, reward, relapse, and upkeep of behavior change).

Studies to evaluate the finish consequence of financing and business and managing factors on usage of and make use of, quality, efficiency, costs, and outcomes of prevention and treatment services.

Research to discover the success, cost-effectiveness, and price-advantages of substance abuse prevention and treatment services.

Substance abuse service delivery systems and models, for example continuity of care, advancement of therapeutic rapport, service linkages and integration models.

Studies that advance the adoption and implementation of evidence-based substance abuse prevention and treatment interventions into service delivery systems (e.g. niche care, primary care, criminal justice, child welfare).

Substance abuse treatment and prevention services for Aids seropositive patients as well as for individuals prone to Aids infection along with other illnesses which derive from substance abuse.

Studies concentrating on management strategies (e.g. work team models, quality management) and business practices fond of growing the conventional, effectiveness, and efficiency of substance abuse treatment and prevention services.

Research concentrating on the expansion or improvement of research methods—including whilst not restricted to study design, measurement, data collection, and analytic procedures—for searching within the societal impact of substance abuse and/or possibly the delivery, quality, outcomes, and immediate and ongoing expenses of substance abuse prevention or treatment services.

In addition to Sex/Gender Variations:

Through this dissertation award program, NIDA seeks to market research on females (both humans plus animal models) and sex/gender variations in lots of areas of substance abuse research. From fundamental cellular and genetics research to epidemiology, prevention, treatment, and services research, investigators ought to research the potential libidoOrsex variations in their selected part of study and to explore substance abuse issues specific to females. Types of research areas include, but aren’t limited to another:

Sex/Gender variations within the fundamental behavior, physiological, neurobiological and genetic mechanisms underlying substance abuse and addiction and laboratory (both human and animal), clinical, and epidemiological studies of sex/gender variations within the determinants of initiation, progression, repair of drug abuse and addiction, and responsiveness to treatment.

Laboratory (both human and animal), field, and clinical research fond of: (1) identifying sex/gender variations within the outcomes of drug abuse, abuse, and addiction following acute use, chronic use, furthermore to residual effects following prolonged abstinence, and (2) analyzing drug-related effects which are unique to females.

Studies fond of characterizing sex variations within the connection between drug exposure across the developing brain, or studies fond of finding sex variations in acute and chronic drug abuse effects (and abstinence effects) across the brains of babies, adolescents and adults.

Using sex/gender-specific theories and empirical research across the origins, pathways, and risk and protective factors associated with drug abuse, progression/transition, and maintenance, for that design, development, and testing of gender-sensitive prevention and treatment strategies and interventions to uncover effectiveness and effectiveness.

The expansion and testing of theoretically-based medications approaches (including behavior treatment and pharmacotherapies) that address sex/gender-specific topics connected while using efficient and effective delivery of substance abuse treatment services.

The expansion and look for sex/gender-specific interventions interested in stopping Aids infection and treating Aids/AIDS among drug using populations.

For additional research areas of interest coping with in addition to sex/gender variations, see https://grants.nih.gov/grants/guide/pa-files/PA-11-047.html .

Queries about the relevance in the particular research prone to NIDA’s scientific mission along with other questions on this FOA must be addressed for that program contact listed under Queries. Potential applicants are strongly requested to talk about their application while using the appropriate program contact.

Aids/AIDS Counseling and Testing Insurance policy for your nation’s Institute on Substance Abuse: Considering recent significant advances in rapid testing for Aids plus effective treating Aids, NIDA has revised its 2001 policy on Aids counseling and testing. NIDA-funded researchers are strongly requested to provide and/or refer research subjects to Aids risk reduction education and education about the advantages of Aids treatment, counseling and testing, referral to treatment, along with other appropriate interventions to avoid acquisition and transmission of Aids. This insurance policy pertains to all NIDA funded research conducted domestically or worldwide. For more information see https://grants.nih.gov/grants/guide/notice-files/NOT-DA-07-013.html .

National Advisory Council on Substance Abuse Suggested Guidelines for the Administration of drugs to Human Subjects: The Nation’s Advisory Council on Substance Abuse (NACDA) recognizes the need for research in regards to the administration of drugs with abuse potential, and dependence or addiction liability, to human subjects. Potential applicants must obtain and review these recommendations of Council before submitting a credit card applicatoin which will administer compounds to human subjects. The rules can be found on NIDA’s Site at

Details to consider Regarding Tobacco Industry Funding of NIDA Applicants: The Nation’s Advisory Council on Substance Abuse (NACDA) encourages NIDA that is grantees to think about precisely what it’s established regarding existing or prospective backed research contracts with tobacco companies or their related entities along with the impact of acceptance of tobacco industry funding on NIDA’s credibility and standing inside the scientific community. Take a look at (ww2.drugabuse.gov/about/organization/nacda/points-to-consider.html ) for details.

Data Harmonization for Drug Abuse and Addiction using the PhenX Toolkit: NIDA strongly encourages investigators connected with human-subjects studies to teach around the common tools and sources which will promote the plethora of comparable data across studies and to accomplish this with the measures inside the Core and Niche collections, accessible within the Drug Abuse and Addiction Selection of the PhenX Toolkit (internet.phenxtoolkit.org). Take a look at NOT-DA-12-008 (https://grants.nih.gov/grants/guide/notice-files/NOT-DA-12-008.html ) to learn more.

Section II. Award Information